Romano Brothers & Co’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.78M Sell
13,504
-75
-0.6% -$19.7K 0.38% 76
2026
Q1
$3.62M Sell
13,579
-34
-0.2% -$9.21K 0.41% 74
2025
Q4
$3.42M Hold
13,613
0.39% 74
2025
Q3
$3.91M Hold
13,613
0.45% 68
2025
Q2
$3.57M Sell
13,613
-350
-3% -$85.2K 0.44% 67
2025
Q1
$3.25M Sell
13,963
-80
-0.6% -$19.4K 0.42% 68
2024
Q4
$3.22M Sell
14,043
-20
-0.1% -$4.59K 0.41% 73
2024
Q3
$3.14M Hold
14,063
0.39% 82
2024
Q2
$2.86M Sell
14,063
-100
-0.7% -$20.3K 0.4% 75
2024
Q1
$3.09M Sell
14,163
-800
-5% -$176K 0.42% 76
2023
Q4
$3.4M Sell
14,963
-150
-1% -$31.5K 0.51% 63
2023
Q3
$3.04M Sell
15,113
-2,636
-15% -$556K 0.47% 66
2023
Q2
$3.67M Sell
17,749
-174
-1% -$33.8K 0.55% 59
2023
Q1
$3.49M Sell
17,923
-972
-5% -$200K 0.54% 63
2022
Q4
$3.82M Buy
18,895
+116
+0.6% +$22.7K 0.58% 52
2022
Q3
$3.31M Buy
+18,779
New +$3.84M 0.53% 61

Other funds holding LH

Romano Brothers & Co's LH Position: Q2 2026 in Review

Romano Brothers & Co reduced its Labcorp (LH) stake by 0.55% in Q2 2026, selling an estimated $19.7K and leaving 13,504 shares worth $3.78M. The position accounts for 0.38% of the portfolio, ranked #76.

Romano Brothers & Co first reported a position in LH in Q3 2022 and has held it in 16 quarters since. The position peaked at $3.91M in Q3 2025. 265 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Romano Brothers & Co held 13,504 shares of Labcorp worth $3.78M as of Q2 2026.
  • Romano Brothers & Co sold 75 Labcorp shares in Q2 2026, an estimated $19.7K.
  • Labcorp made up 0.38% of Romano Brothers & Co's portfolio in Q2 2026, its #76 holding.
  • Romano Brothers & Co first reported a position in Labcorp in Q3 2022 and has held it in 16 quarters since.
  • Romano Brothers & Co's Labcorp position peaked at $3.91M in Q3 2025.
  • 265 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Romano Brothers & Co's 13F filing for Q2 2026, filed 22 Jul 2026.